A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer (Q66038649)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer |
clinical trial |
Statements
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of 10 Mg Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer (English)
0 references
May 2001
0 references
1,000
0 references
19 year
0 references